Please complete the form below and a member of the BOTOX® (botulinum toxin type A) team will get back to you.
Please fill in your details below only if you are a UK registered healthcare professional and would like to be contacted by an AbbVie representative.
BOTOX® (botulinum toxin type A) is indicated for the treatment of focal spasticity including: wrist and hand disability due to upper limb spasticity associated with stroke in adults; ankle and foot disability due to lower limb spasticity associated with stroke in adults.1
The BOTOX® (botulinum toxin type A) prescribing information and adverse event reporting information can be found at the bottom of the page.
Date of preparation: January 2023. UK-BTX-220212.